DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

Dexamethasone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 2 EU WC, 7 KDMF, 26 NDC API, 2 VMF, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

218 Drugs in Development

218 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 27 Canada, 10 Australia, 17 South Africa, 64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 1.5MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 4MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 2MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML, TABLET;ORAL - 1MG, TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 7 SPI Pharma, 8 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Thickeners and Stabilizers, 25 Solubilizers, 22 Controlled & Modified Release, 20 Parenteral, 20 Topical, 19 Film Formers & Plasticizers, 19 Disintegrants & Superdisintegrants, 17 Co-Processed Excipients, 17 Taste Masking, 16 Granulation, 13 Lubricants & Glidants, 9 Chewable & Orodispersible Aids, 9 Rheology Modifiers, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 264 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 110 Finished Drug Prices, 6 Annual Reports

MARKET PLACE

61 APIs, 59 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 3 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 2 USP, 2 JP, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	EUROAPI	France	EUROAPI FRANCE	218MF10376	Dexamethasone	2006-03-20	2024-08-22	15 rue Traversie(')re 75012 Paris France
26/09/2024	Curia	U.S.A	Curia Spain S. A. U.	218MF10748	JP Dexamethasone (for manufacturing only)	2006-09-06	2010-03-17	Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain

Dexamethasone

Dexamethasone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers

26 USDMF

9 CEP/COS

6 JDMF

2 EU WC

7 KDMF

26 NDC API

2 VMF

50 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

218 Drugs in Development

INTERMEDIATES

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

130 FDA Orange Book

113 Europe

27 Canada

10 Australia

17 South Africa

64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%

OINTMENT;OPHTHALMIC - 0.1%;0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

TABLET;ORAL - 1.5MG

TABLET;ORAL - 0.5MG

TABLET;ORAL - 4MG

TABLET;ORAL - 0.75MG

TABLET;ORAL - 2MG

SOLUTION;ORAL - 0.5MG/5ML

ELIXIR;ORAL - 0.5MG/5ML

TABLET;ORAL - 1MG

TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

7 SPI Pharma

8 DKSH

2 Jai Radhe Sales

1 Pharm-RX Chemical

13 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

15 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

10 Corel Pharma Chem

1 Curia

6 DFE Pharma

3 Finar

8 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

1 Novo Excipients

1 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

15 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical